The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Ibuprofen Interferes with the Efficacy of Antihypertensive Drugs: A Randomized, Double-Blind, Placebo-Controlled Trial of Ibuprofen Compared with Acetaminophen
Abstract
Study Objective: To assess the effects of Ibuprofen on blood pressure control in patients being treated with antihypertensive drugs. Design: Randomized, blinded, placebo-controlled, parallel trial of Ibuprofen compared with acetaminophen and with placebo in 3-week treatment periods. Setting: A general internal medicine clinic at a university hospital. Patients: Forty-five patients with essential hypertension controlled by treatment with at least two antihypertensive drugs were enrolled. Of these, 41 completed the study; treatment was discontinued in 3 of the 15 patients in the Ibuprofen group due to breakage of the drug capsules, and after randomization in 1 of the 14 patients in the placebo group due to unstable angina. All 15 patients in the acetaminophen group completed the study. Interventions: All previous antihypertensive regimens were continued. During the 3-week treatment, Ibuprofen, 400 mg, was administered orally every 8 hours; acetaminophen, 1 g, orally every 8 hours; or placebo, 2 capsules, orally every 8 hours. Measurements and Main Results: In the Ibuprofen group, the mean increase from baseline after 3 weeks of treatment was significant in the average supine diastolic blood pressure (6.4 mm Hg; 95% confidence interval [Cl], 1.05 to 11.75; p = 0.0239); supine mean arterial pressure (6.6 mm Hg; 95% Cl, 1.25 to 11.95; & p = 0.0205); and sitting mean arterial pressure (5.8 mm Hg; 95% Cl, 1.57 to 10.04; p = 0.0123). The mean increase in blood pressure variables in the Ibuprofen group was significantly different compared with the mean increase in the variables in the placebo group after 3 weeks of treatment: supine systolic blood pressure (7.1 mm Hg compared with -4.5 mm Hg; 95% Cl for the difference in means, 2.5 to 20.6; p = 0.0133); supine diastolic pressure (6.4 mm Hg compared with 0.0; 95% Cl for difference in means, 0.87 to 12.4; p = 0.0250); supine mean arterial pressure (6.6 mm Hg compared with -1.5; 95% Cl for difference in means, 2.0 to 14.2; p= 0.0110); sitting systolic pressure (6.8 mm Hg compared with -3.7; 95% Cl for difference in means, 2.0 to 19.0; p = 0.0169); sitting diastolic pressure (5.3 mm Hg compared with -1.1; 95% Cl for difference in means, 0.76 to 12.1; p = 0.0273); and sitting mean arterial pressure (5.8 mm Hg compared with -2.0; 95% Cl for difference in means, 1.5 to 14.1; p = 0.0169). When compared with the acetaminophen group after 3 weeks of treatment, the Ibuprofen group also showed statistically significant changes in supine diastolic and mean arterial pressures, and sitting diastolic and mean arterial pressures. Conclusions: Ibuprofen can interfere with blood pressure control in certain patients with treated mild-to-moderate hypertension. Further clinical studies are needed to document these findings and determine which patients are most likely to have an ibuprofen-related impairment in blood pressure control.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, NSAIDs affect the treatment effect of several antihypertensive medication classes, including diuretics, ACE inhibitors, ARBs, and β-blockers.184,185”
From Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association (2018) · cites this paper as [184]
Citations
Cites
Renal Syndromes Associated with Nonsteroidal Antiinflammatory Drugs
Clive, D. M., & Stoff, J. S. (1984) · New England Journal of Medicine · doi:10.1056/nejm198403013100905 · Cited by 1,127
Effects of Sulindac and Ibuprofen in Patients with Chronic Glomerular Disease
Ciabattoni, G., Cinotti, G. A., Pierucci, A., Simonetti, B. M., Manzi, M., Pugliese, F. R., Barsotti, P., Pecci, G., Taggi, F., & Patrono, C. (1984) · New England Journal of Medicine · doi:10.1056/nejm198402023100502 · Cited by 329
Antagonism of the effects of furosemide by in domethacin in normal and hypertensive man
Patak, R. V., Mookerjee, B. K., Bentzel, C. J., Hysert, P., Babej, M., & Lee, J. B. (1975) · Prostaglandins · doi:10.1016/s0090-6980(75)80012-8 · Cited by 264
Arachidonic acid metabolism, prostaglandins and the kidney
Levenson, D. J., Simmons, C. E., & Brenner, B. M. (1982) · The American Journal of Medicine · doi:10.1016/0002-9343(82)90826-9 · Cited by 224
Garella, S., & Matarese, R. A. (1984) · Medicine · doi:10.1097/00005792-198405000-00003 · Cited by 221
Attenuation of hypotensive effect of propranolol and thiazide diuretics by indomethacin.
Watkins, J. B., Abbott, E., Hensby, C. N., Webster, J., & Dollery, C. T. (1980) · BMJ · doi:10.1136/bmj.281.6242.702 · Cited by 181
Kirkendall, W. M., Feinleib, M., Freis, E. D., & Mark, A. L. (1980) · PubMed · Cited by 171
Durão, V., Prata, M. M., & Gonçalves, L. M. P. (1977) · The Lancet · doi:10.1016/s0140-6736(77)92899-9 · Cited by 142
Dg, W., LAMKI, L. M., Spence, J. D., Freeman, D., & McDonald, J. W. D. (1986) · The Lancet · doi:10.1016/s0140-6736(86)91271-7 · Cited by 126
Chalmers, J. P., West, M., Wing, L. M. H., Bune, A. J. C., & Graham, J. R. (1984) · Clinical and Experimental Hypertension · doi:10.3109/10641968409039582 · Cited by 88
Research works printed but not linked: 12
- LOPEZ-OVEJERO J, 1978, Clin Sci Mol Med., 55, 203s
- CHALMERS J, 1984, Clin Exper Hypertens [A]., 6, 1077
- EBEL D, 1985, Advances in Therapy, 2, 131
- REGESTER R, 1980, J Tenn Med Assoc., 73, 709
- LEE R, 1983, Can Med Assoc J, 129, 854
- POIRIER T, 1984, Drug Intell Clin Pharm., 18, 2732
- RADACK K, 1987, J Gen InMed., 2, 108
- KIRKENDALL W, 1980, Circulation., 62, 1146A
- COHEN E, 1971, J Lab Clin Med., 77, 1025
- DANIEL W . Biostatistics: A Foundation for Analysis in the Health Sciences. 3rd ed. New York: Wiley and Sons; 1983;411-6.
- LINTON A, 1984, Can Med Assoc J., 131, 189
- LEVENSON D, Kidney Int., 1980, 609
Cited by
Sorted by citations
Resistant Hypertension: Diagnosis, Evaluation, and Treatment
Calhoun, D. A., Jones, D. W., Textor, S. C., Goff, D. C., Murphy, T. P., Toto, R. D., White, A. J., Cushman, W. C., White, W. B., Sica, D. A., et al. (2008) · Circulation · doi:10.1161/circulationaha.108.189141 · Cited by 2,240
Resistant Hypertension: Diagnosis, Evaluation, and Treatment
Calhoun, D. A., Jones, D. W., Textor, S. C., Goff, D. C., Murphy, T. P., Toto, R. D., White, A. J., Cushman, W. C., White, W. B., Sica, D. A., et al. (2008) · Hypertension · doi:10.1161/hypertensionaha.108.189141 · Cited by 1,416
Carey, R. M., Calhoun, D. A., Bakris, G. L., Brook, R. D., Daugherty, S. L., Dennison-Himmelfarb, C. R., Egan, B. M., Flack, J. M., Gidding, S. S., Judd, E., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000084 · Cited by 1,153
Graham, G. G., Davies, M. J., Day, R. O., Mohamudally, A., & Scott, K. F. (2013) · Inflammopharmacology · doi:10.1007/s10787-013-0172-x · Cited by 671
Ibuprofen: pharmacology, efficacy and safety
Rainsford, K. D. (2009) · Inflammopharmacology · doi:10.1007/s10787-009-0016-x · Cited by 699
A Meta-analysis of the Effects of Nonsteroidal Anti-inflammatory Drugs on Blood Pressure
Pope, J. E. (1993) · Archives of Internal Medicine · doi:10.1001/archinte.1993.00410040045007 · Cited by 527
Clinical Implications of Prostaglandin and Thromboxane A2Formation
Oates, J. A., FitzGerald, G. A., Branch, R. A., Jackson, E. K., Knapp, H. R., & Roberts, L. J. (1988) · New England Journal of Medicine · doi:10.1056/nejm198809223191206 · Cited by 444
Clinical Pharmacokinetics of Ibuprofen
Davies, N. M. (1998) · Clinical Pharmacokinetics · doi:10.2165/00003088-199834020-00002 · Cited by 442
Nonsteroidal Anti-Inflammatory Drugs and the Kidney
Hörl, W. H. (2010) · Pharmaceuticals · doi:10.3390/ph3072291 · Cited by 298
Renal complications of nonsteroidal anti-inflammatory drugs
Schlöndorff, D. (1993) · Kidney International · doi:10.1038/ki.1993.293 · Cited by 278
Epidemiology of Nonsteroidal Anti-inflammatory Drug–Associated Gastrointestinal Injury
Griffin, M. R. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)00207-6 · Cited by 274
Pierce, C. A., & Voss, B. (2010) · Annals of Pharmacotherapy · doi:10.1345/aph.1m332 · Cited by 255
Drug-induced Hypertension: An Unappreciated Cause of Secondary Hypertension
Grossman, E., & Messerli, F. H. (2012) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.05.024 · Cited by 183
Adverse drug interactions involving common prescription and over-the-counter analgesic agents
Hersh, E. V., Pinto, A., & Moore, P. A. (2007) · Clinical Therapeutics · doi:10.1016/j.clinthera.2007.12.003 · Cited by 182
Mazaleuskaya, L. L., Theken, K. N., Gong, L., Thorn, C. F., FitzGerald, G. A., Altman, R. B., & Klein, T. E. (2014) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0000000000000113 · Cited by 183
Over-the-counter analgesics and antipyretics: A critical assessment
Hersh, E. V., Moore, P. A., & Ross, G. L. (2000) · Clinical Therapeutics · doi:10.1016/s0149-2918(00)80043-0 · Cited by 180
Frequency of Analgesic Use and Risk of Hypertension in Younger Women
Curhan, G. C., Willett, W. C., ROSNER, B. A., & Stampfer, M. J. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.19.2204 · Cited by 179
Acetaminophen Increases Blood Pressure in Patients With Coronary Artery Disease
Sudano, I., Flammer, A. J., Périat, D., Enseleit, F., Hermann, M., Wolfrum, M., Hirt, A., Kaiser, P., Hürlimann, D., Neidhart, M., et al. (2010) · Circulation · doi:10.1161/circulationaha.110.956490 · Cited by 176
Desforges, J. F., Setaro, J. F., & Black, H. R. (1992) · New England Journal of Medicine · doi:10.1056/nejm199208203270808 · Cited by 130
NSAIDs and Increased Blood Pressure
Johnson, A. G. (1997) · Drug Safety · doi:10.2165/00002018-199717050-00001 · Cited by 122
ORCA: OpeRational ClassificAtion of Drug Interactions
Hansten, P. D., Horn, J. R., & Hazlet, T. K. (2001) · Journal of the American Pharmaceutical Association (1996) · doi:10.1016/s1086-5802(16)31244-x · Cited by 98
Johnson, A. G. (1998) · Drugs & Aging · doi:10.2165/00002512-199812010-00003 · Cited by 91
Aljadhey, H. S., Tu, W., Hansen, R. A., Blalock, S. J., Brater, D. C., & Murray, M. D. (2012) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-12-93 · Cited by 92
Common Secondary Causes of Resistant Hypertension and Rational for Treatment
Faselis, C. J., Doumas, M. N., & Papademetriou, V. (2011) · International Journal of Hypertension · doi:10.4061/2011/236239 · Cited by 89
Ibuprofen and Paracetamol: Relative Safety in Non-prescription Dosages
Rainsford, K. D., Roberts, S. C., & Brown, S. A. (1997) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1997.tb06809.x · Cited by 76
Interaction between antihypertensives and NSAIDs in primary care: a controlled trial.
Pavličević, I., Kuzmanić, M., Rumboldt, M., & Rumboldt, Z. (2008) · PubMed · Cited by 75
Sperber, S. J., Sorrentino, J. V., Riker, D. K., & Hayden, F. G. (1989) · PubMed Central · Cited by 74
Alchin, J., Dhar, A., Siddiqui, K., & Christo, P. J. (2022) · Current Medical Research and Opinion · doi:10.1080/03007995.2022.2049551 · Cited by 65
RUOFF, G. E. (1998) · Clinical Therapeutics · doi:10.1016/s0149-2918(98)80049-0 · Cited by 65
Analgesic Use and Risk of Subsequent Hypertension in Apparently Healthy Men
Kurth, T., Hennekens, C. H., Stürmer, T., Sesso, H. D., Glynn, R. J., Buring, J. E., & Gaziano, J. M. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.16.1903 · Cited by 61
Adverse drug interactions in dentistry
Hersh, E. V., & Moore, P. A. (2008) · Periodontology 2000 · doi:10.1111/j.1600-0757.2008.00224.x · Cited by 58
Adverse Drug Interactions with Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
Johnson, A. G., Seideman, P., & Day, R. O. (1993) · Drug Safety · doi:10.2165/00002018-199308020-00002 · Cited by 56
Calhoun, D. A., Zaman, M. A., & Nishizaka, M. (2002) · Current Hypertension Reports · doi:10.1007/s11906-002-0011-8 · Cited by 54
Prospects for changing the burden of nonsteroidal anti-inflammatory drug toxicity
Griffin, M. R., & Scheiman, J. M. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00634-3 · Cited by 53
Management of Difficult to Control Hypertension
Graves, J. W. (2000) · Mayo Clinic Proceedings · doi:10.4065/75.3.278 · Cited by 47
Turtle, E. J., Dear, J. W., & Webb, D. J. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12032 · Cited by 48
Nonsteroidal Antiinflammatory Drugs, Acetaminophen, and Hypertension
Sudano, I., Flammer, A. J., Roas, S., Enseleit, F., Noll, G., & Ruschitzka, F. T. (2012) · Current Hypertension Reports · doi:10.1007/s11906-012-0274-7 · Cited by 45
The Effects of Pain and Analgesic Medications on Blood Pressure
Rivasi, G., Menale, S., Turrin, G., Coscarelli, A., Giordano, A., & Ungar, A. (2022) · Current Hypertension Reports · doi:10.1007/s11906-022-01205-5 · Cited by 48
Gurwitz, J. H., Everitt, D. E., Monane, M., Glynn, R., Choodnovskiy, I., Beaudet, M., & Avorn, J. (1996) · The Journals of Gerontology Series A · doi:10.1093/gerona/51a.2.m74 · Cited by 38
Tegeder, I., & Geißlinger, G. (2006) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-006-0044-7 · Cited by 36
Standards of laboratory practice: analgesic drug monitoring
White, S. R., & Wong, S. H. (1998) · Clinical Chemistry · doi:10.1093/clinchem/44.5.1110 · Cited by 35
Klassen, D. K., Young, D. Y., & Peterson, C. A. (1995) · American Journal of Hypertension · doi:10.1016/0895-7061(94)00164-7 · Cited by 35
Nonsteroidal anti-inflammatory drugs in patients with cardioor cerebrovascular disorders
St�llberger, C., & Finsterer, J. (2003) · Zeitschrift für Kardiologie · doi:10.1007/s00392-003-0964-x · Cited by 34
Prevalence and characteristics of resistant hypertensive patients in an Asian population
Naseem, R., Adam, A. M., Khan, F., Dossal, A., Khan, I., Khan, A., Paul, H., Jawed, H., Aslam, A., Syed, F. M., et al. (2017) · Indian Heart Journal · doi:10.1016/j.ihj.2017.01.012 · Cited by 29
Drug interactions and the clinical anaesthetist
Dawson, J., & Karalliedde, L. D. (1998) · European Journal of Anaesthesiology · doi:10.1111/j.0265-0215.1998.00269.x · Cited by 28
Resistant or Difficult‐to‐Treat Hypertension
Calhoun, D. A. (2006) · Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2006.04747.x · Cited by 28
Klassen, D. K., Goodfriend, T. L., Schuna, A. A., Young, D. Y., & Peterson, C. A. (1993) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1993.tb01932.x · Cited by 24
Thakur, V. (1999) · American Journal of Hypertension · doi:10.1016/s0895-7061(99)00075-8 · Cited by 24
Clinical Pharmacology and Use of Nonsteroidal Anti-Inflammatory Drugs
Mortensen, M. E., & Rennebohm, R. M. (1989) · Pediatric Clinics of North America · doi:10.1016/s0031-3955(16)36761-x · Cited by 24
Drug-induced causes of secondary hypertension
Aronow, W. S. (2017) · Annals of Translational Medicine · doi:10.21037/atm.2017.06.16 · Cited by 24
Cardiovascular risk associated with high sodium-containing drugs: A systematic review
Perrin, G., Korb‐Savoldelli, V., Karras, A., Danchin, N., Durieux, P., & Sabatier, B. (2017) · PLoS ONE · doi:10.1371/journal.pone.0180634 · Cited by 23
Nonprescription drugs and hypertension
Bradley, J. G. (1991) · Postgraduate Medicine · doi:10.1080/00325481.1991.11700928 · Cited by 23
Lubinga, S. J., & Uwiduhaye, E. (2011) · PubMed Central · Cited by 22
Gualtierotti, R., Zoppi, A., Mugellini, A., Derosa, G., D’Angelo, A., & Fogari, R. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.816286 · Cited by 21
Furey, S. A., Vargas, R., & McMahon, F. G. (1993) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1993.tb02699.x · Cited by 22
Kimberly, R. P. (1988) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(21)00955-8 · Cited by 22
Prescott, L., Mattison, P. C., Menzies, D., & Manson, L. (1990) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1990.tb03657.x · Cited by 21
Secondary Hypertension due to Drugs and Toxins
Gyamlani, G. G., & Geraci, S. A. (2007) · Southern Medical Journal · doi:10.1097/smj.0b013e318063c3e8 · Cited by 18
Areas of Emerging Interest in Analgesia: Cardiovascular Complications
Hillis, W. S. (2002) · American Journal of Therapeutics · doi:10.1097/00045391-200205000-00011 · Cited by 19
Weinstein, R. D., Gribbin, J. J., & Muske, K. R. (2004) · Journal of Chemical & Engineering Data · doi:10.1021/je0497202 · Cited by 19
Sica, D. A., & Prisant, L. M. (2007) · Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2007.06504.x · Cited by 18
Antihypertensive therapy: special focus on drug interactions
Maas, R., & Böger, R. H. (2003) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2.6.549 · Cited by 18
Ahmed, O. G., & El-Mottaleb, N. A. A. (2012) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-012-0182-y · Cited by 17
Does paracetamol cause hypertension?
Montgomery, B. D. (2008) · BMJ · doi:10.1136/bmj.39526.654016.ad · Cited by 17
Valeshabad, A. K., Nabavian, O., Nourijelyani, K., Kord, H., Vafainejad, H., Valeshabad, R. K., Feili, A. R., Rezaee, M., Darabi, H., Koohkan, M., et al. (2014) · Anesthesiology Research and Practice · doi:10.1155/2014/170247 · Cited by 16
Current Issues in NSAID Therapy
Miller, L. G., & Prichard, J. G. (1990) · Primary Care Clinics in Office Practice · doi:10.1016/s0095-4543(21)00885-x · Cited by 16
Salort-Llorca, C., Serra, M. P. M., & Donat, F. J. S. (2008) · PubMed · Cited by 15
Pharmacological interactions of anti-inflammatory-analgesics in odontology.
Moreno, G. G., Guardia, J., Cutando, A., & Calvo‐Guirado, J. L. (2009) · PubMed · Cited by 15
Takeuchi, K., Abe, K., Yasujima, M., Sato, M., Tanno, M., Sato, K., & YOSHINAGA, K. (1991) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.165.201 · Cited by 15
Resistant Hypertension: Underlying Causes and Treatment
Sarwar, M. S., Islam, M. S., Baker, S. M. A., & Hasnat, A. (2013) · Drug Research · doi:10.1055/s-0033-1337930 · Cited by 14
Engelhardt, G., Homma, D., Schlegel, K., Schnitzler, C., & Utzmann, R. (1996) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(95)02035-7 · Cited by 13
Ibuprofen and Postpartum Blood Pressure in Women With Hypertensive Disorders of Pregnancy
Penfield, C. A., McNulty, J. A., Oakes, M. C., & Nageotte, M. P. (2019) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000003553 · Cited by 12
Southwestern Internal Medicine Conference: Analgesic Nephropathy
Henrich, W. L. (1988) · The American Journal of the Medical Sciences · doi:10.1097/00000441-198806000-00012 · Cited by 12
Therapeutics of Ibuprofen in Rheumatic and Other Chronic and Painful Diseases
Kean, W. F., Rainsford, K. D., & Buchanan, W. W. (2015) · Wiley eBooks · doi:10.1002/9781118743614.ch6 · Cited by 12
Effect of Naproxen and Sulindac on Blood Pressure Response to Atenolol
Abate, M. A., Layne, R. D., Neely, J. L., & D’Alessandri, R. M. (1990) · DICP · doi:10.1177/106002809002400901 · Cited by 11
Drugs that increase blood pressure
Sander, G. E. (2011) · Therapy · doi:10.2217/thy.11.25 · Cited by 10
Amlodipine and haemodynamic effects of cyclo‐oxygenase inhibition.
Minuz, P., Pancera, P., Ribul, M., Priante, F., Degan, M., Campedelli, A., Arosio, E., & Lechi, A. (1995) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1995.tb04408.x · Cited by 10
Nonnarcotic Analgesic Use and the Risk of Hypertension in US Women
Egan, B. M. (2002) · Hypertension · doi:10.1161/01.hyp.0000035857.73890.67 · Cited by 10
Drug Interactions in Hypertensive Patients
Lam, Y. W. F., & Shepherd, A. M. M. (1990) · Clinical Pharmacokinetics · doi:10.2165/00003088-199018040-00003 · Cited by 9
Treatment Resistant Hypertension
Bolli, P. (2008) · American Journal of Therapeutics · doi:10.1097/mjt.0b013e318164c67b · Cited by 8
Lack of Interaction Between Sulindac or Naproxen and Propranolol in Hypertensive Patients
Schuna, A. A., Vejraska, B. D., Hiatt, J. G., Kochar, M. S., Day, R. P., & Goodfriend, T. L. (1989) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1989.tb03375.x · Cited by 8
Payne, T. H., Goroll, A. H., Morgan, M. M., & Barnett, G. O. (1990) · Computers and Biomedical Research · doi:10.1016/0010-4809(90)90034-a · Cited by 8
Selecting nonsteroidal anti-inflammatory drugs: pharmacologic and clinical considerations.
Miller, L. G., & Prichard, J. G. (1989) · PubMed · Cited by 8
Balancing the evidence: An update on analgesic use in rheumatic and musculoskeletal diseases
Huang, Y.-T., McCarthy, C., & Jani, M. (2023) · Frontiers in Drug Safety and Regulation · doi:10.3389/fdsfr.2023.1117674 · Cited by 7
Hypertensive Crisis: The Causative Effects of Nonsteroidal Anti- Inflammatory Drugs
Landefeld, K., Gonzales, H. M., & Sander, G. E. (2016) · Journal of Clinical Case Reports · doi:10.4172/2165-7920.1000860 · Cited by 7
Drug interactions and the clinical anaesthetist
Dawson, J., & Karalliedde, L. D. (1998) · European Journal of Anaesthesiology · doi:10.1097/00003643-199803000-00009 · Cited by 7
The Unknown Impacts of Combinations of Large Numbers of Drugs
Kostoff, R. N., & Delafuente, J. C. (2006) · Drug Safety · doi:10.2165/00002018-200629030-00001 · Cited by 7
Neutralization of the effects of captopril by the use of ibuprofen in an elderly woman.
Espino, D. V., & Lancaster, M. C. (1992) · PubMed · Cited by 7
Prisant, L. M. (2005) · Elsevier eBooks · doi:10.1016/b978-0-7216-0258-5.50156-3 · Cited by 7
Gupta, R., Behnoush, A. H., Egeler, D., & Aronow, W. S. (2022) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwac112 · Cited by 6
Evaluation of the relationship between effervescent paracetamol and blood pressure: clinical trial
Benítez, M., Vinyoles, E., Rebagliato-Nadal, O., Morros, R., Pera, H., Dalfó-Baqué, A., López-Pavón, I., Roca-Sánchez, C., Coma-Carbó, R. M., von Wichmann, M. D. L. F., et al. (2015) · BMC Cardiovascular Disorders · doi:10.1186/s12872-015-0161-7 · Cited by 5
Non-steroidal anti-inflammatory drugs (NSAIDs)
(2015) · Elsevier eBooks · doi:10.1016/b978-0-444-53717-1.01165-3 · Cited by 5
Wolfe, F., Michaud, K. D., & Zhao, S. Z. (2003) · JCR Journal of Clinical Rheumatology · doi:10.1097/01.rhu.0000099744.85700.50 · Cited by 5
Identifying Patients With Resistant Hypertension and Options for Clinical Management
Cheung, T. T., & Cheung, B. M. Y. (2012) · Future Cardiology · doi:10.2217/fca.12.66 · Cited by 4
Provider-directed analgesia for dental pain
Myers, A. L., & Jeske, A. H. (2023) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2023.2206118 · Cited by 5
Quelles sont les complications cardiovasculaires des antalgiques et des glucocorticoides?
Dufauret-Lombard, C., & Bertin, P. (2006) · La Presse Médicale · doi:10.1016/s0755-4982(06)74940-5 · Cited by 4
Factores que influyen en la hipertensión arterial refractaria
de la Morena, J. S., Sien, C. C., & Urioste, L. M. R. (2002) · Hipertensión y Riesgo Vascular · doi:10.1016/s1889-1837(02)71260-9 · Cited by 4
Current status of nephrotoxicity caused by non-steroidal anti-inflammatory drugs
Prescott, L. F., & Martin, U. (1992) · Inflammation and drug therapy series · doi:10.1007/978-94-011-2982-4_27 · Cited by 4
Maintenance of Blood Pressure Control in Elderly Hypertensives on Ketoprofen
Weiss, Y., Chénard, A., Kermadec, J. M. D., Tertrain, F., & Abiteboul, M. (1991) · Scandinavian Journal of Rheumatology · doi:10.3109/03009749109096949 · Cited by 4
Safety and Efficacy of Non‐prescription, Over‐the‐Counter (OTC) Ibuprofen
Rainsford, K. D. (2015) · doi:10.1002/9781118743614.ch7 · Cited by 3
Metadata
- Authors
- RADACK, K. L., DECK, C. C., & BLOOMFIELD, S. S.
- Affiliations
- University of Cincinnati (US)
- Cincinnati, Ohio
- Corresponding author
- RADACK, KENNETH L
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 1987-11-01
- Volume
- 107
- Issue
- 5
- Pages
- 628-635
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W1973757442
- Cited by
- 140
- References
- 27
- Citations by year
- 2024: 2 · 2023: 2 · 2022: 3 · 2021: 1 · 2019: 1 · 2018: 1 · 2017: 3 · 2016: 1 · 2015: 8 · 2014: 3 · 2013: 5 · 2012: 8
- FWCI
- 7.33
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Keywords
- ibuprofen, antihypertensive drugs, essential hypertension, drug interactions, blood pressure control, paracetamol, nonsteroidal anti-inflammatory drugs, diastolic blood pressure, mean arterial pressure, combination therapy, adverse drug reactions, drug discontinuation, angina pectoris
- MeSH terms
- Acetaminophen, Adrenergic beta-Antagonists, Adult, Aged, Antihypertensive Agents, Blood Pressure, Clinical Trials as Topic, Double-Blind Method, Female, Humans, Hypertension, Ibuprofen, Male, Middle Aged, Random Allocation, Renin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review